New DNA base editors advance towards curing cystic fibrosis and other human point mutation diseases
New DNA base editing platform holds potential for reversing the most common class of disease-associated DNA point mutations. Scientists at Harvard University and the Broad Institute of MIT and Harvard have developed a new class of genome editing tool. This new “base editor” can directly repair the type of single-letter changes in the human genome …